UPDATE: Morgan Stanley Reiterates Equal-Weight Rating, Raises PT on Medicis Pharmaceutical - Marex Group (NASDAQ:MRX)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

In a report published Wednesday, Morgan Stanley reiterated its Equal-Weight rating on Medicis Pharmaceutical Corp. (NYSE: MRX), and raised its price target from $35.00 to $44.00.Morgan Stanley noted, “We are lowering our 2013E EPS by 18% and trimming long- term (2014E-2020E) EPS by 13% on management's disappointing Sep. 17 proxy projections. Separately, we are raising our price target from $35 to reflect Valeant's $44/share bid.”Medicis Pharmaceutical Corp. closed on Tuesday at $43.25.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!